MBX Biosciences (MBX) Competitors $17.00 +0.87 (+5.39%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$16.89 -0.11 (-0.65%) As of 10/24/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBX vs. RCUS, TLRY, TWST, IMCR, BHVN, ABCL, PAHC, JANX, EWTX, and GPCRShould you be buying MBX Biosciences stock or one of its competitors? The main competitors of MBX Biosciences include Arcus Biosciences (RCUS), Tilray Brands (TLRY), Twist Bioscience (TWST), Immunocore (IMCR), Biohaven (BHVN), AbCellera Biologics (ABCL), Phibro Animal Health (PAHC), Janux Therapeutics (JANX), Edgewise Therapeutics (EWTX), and Structure Therapeutics (GPCR). These companies are all part of the "pharmaceutical products" industry. MBX Biosciences vs. Its Competitors Arcus Biosciences Tilray Brands Twist Bioscience Immunocore Biohaven AbCellera Biologics Phibro Animal Health Janux Therapeutics Edgewise Therapeutics Structure Therapeutics Arcus Biosciences (NYSE:RCUS) and MBX Biosciences (NASDAQ:MBX) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment. Which has preferable earnings and valuation, RCUS or MBX? MBX Biosciences has lower revenue, but higher earnings than Arcus Biosciences. Arcus Biosciences is trading at a lower price-to-earnings ratio than MBX Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArcus Biosciences$262M7.04-$283M-$3.17-5.46MBX BiosciencesN/AN/A-$61.92M-$4.54-3.74 Do analysts recommend RCUS or MBX? Arcus Biosciences currently has a consensus price target of $27.22, suggesting a potential upside of 57.16%. MBX Biosciences has a consensus price target of $44.00, suggesting a potential upside of 158.82%. Given MBX Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe MBX Biosciences is more favorable than Arcus Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcus Biosciences 1 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.60MBX Biosciences 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do institutionals and insiders have more ownership in RCUS or MBX? 92.9% of Arcus Biosciences shares are held by institutional investors. 9.6% of Arcus Biosciences shares are held by insiders. Comparatively, 52.2% of MBX Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is RCUS or MBX more profitable? MBX Biosciences has a net margin of 0.00% compared to Arcus Biosciences' net margin of -109.56%. MBX Biosciences' return on equity of -31.33% beat Arcus Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Arcus Biosciences-109.56% -55.96% -25.73% MBX Biosciences N/A -31.33%-29.96% Does the media favor RCUS or MBX? In the previous week, MBX Biosciences had 5 more articles in the media than Arcus Biosciences. MarketBeat recorded 12 mentions for MBX Biosciences and 7 mentions for Arcus Biosciences. MBX Biosciences' average media sentiment score of 1.37 beat Arcus Biosciences' score of 0.55 indicating that MBX Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Arcus Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive MBX Biosciences 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMBX Biosciences beats Arcus Biosciences on 9 of the 13 factors compared between the two stocks. Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBX vs. The Competition Export to ExcelMetricMBX BiosciencesPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$541.87M$1.08B$2.56B$10.65BDividend YieldN/A4.84%2.50%4.82%P/E Ratio-3.741.4622.0830.57Price / SalesN/A30.84106.22176.50Price / CashN/A17.6343.6761.44Price / Book2.218.0133.126.61Net Income-$61.92M-$7.35M$6.87M$277.10M7 Day Performance28.59%2.49%1.14%2.55%1 Month Performance-1.90%29.62%1.43%3.77%1 Year PerformanceN/A-14.24%86.32%33.05% MBX Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBXMBX Biosciences3.513 of 5 stars$17.00+5.4%$44.00+158.8%N/A$541.87MN/A-3.74N/APositive NewsInsider TradeRCUSArcus Biosciences2.7737 of 5 stars$16.49-0.7%$26.78+62.4%-2.9%$1.75B$258M-5.20500Analyst ForecastTLRYTilray Brands3.2326 of 5 stars$1.56+1.3%$2.00+28.2%-9.1%$1.75B$210.48M-0.692,842Analyst ForecastTWSTTwist Bioscience4.0034 of 5 stars$28.16-8.4%$48.56+72.4%-15.2%$1.70B$312.97M-19.42990Analyst ForecastGap UpIMCRImmunocore2.6836 of 5 stars$33.56+0.1%$56.89+69.5%+1.8%$1.69B$310.20M-83.90320News CoverageAnalyst ForecastBHVNBiohaven3.4181 of 5 stars$16.00-2.9%$48.85+205.3%-68.3%$1.69BN/A-2.09239News CoverageAnalyst ForecastABCLAbCellera Biologics2.2769 of 5 stars$5.59-4.3%$8.00+43.1%+109.6%$1.67B$28.83M-10.16500Analyst ForecastGap UpPAHCPhibro Animal Health3.8371 of 5 stars$39.72+3.0%$28.40-28.5%+80.8%$1.61B$1.30B33.662,475News CoverageInsider TradeJANXJanux Therapeutics1.9789 of 5 stars$26.76-1.6%$78.31+192.6%-53.3%$1.61B$10.59M-14.8730News CoverageEWTXEdgewise Therapeutics3.1913 of 5 stars$15.06-1.7%$38.83+157.9%-56.2%$1.59BN/A-9.7260Analyst ForecastGPCRStructure Therapeutics3.3108 of 5 stars$27.38-0.7%$68.67+150.8%-29.6%$1.58BN/A-26.08136Positive News Related Companies and Tools Related Companies RCUS Competitors TLRY Competitors TWST Competitors IMCR Competitors BHVN Competitors ABCL Competitors PAHC Competitors JANX Competitors EWTX Competitors GPCR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MBX) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBX Stock Alerts